Ax­ing staff and shelv­ing can­cer pro­grams, Se­lec­ta hopes laser fo­cus on gout will prove a way out

As Wern­er Cautreels com­pletes his re­tire­ment form Se­lec­ta Bio­sciences, new CEO Carsten Brunn is left on his own to start the year off with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.